- Home
- BNZI vs INTS Comparison
BNZI vs INTS Comparison
Compare BNZI & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- INTS
- Stock Information
- Founded
- BNZI 2016
- INTS 2012
- Country
- BNZI United States
- INTS United States
- Employees
- BNZI N/A
- INTS N/A
- Industry
- BNZI
- INTS Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- INTS Health Care
- Exchange
- BNZI Nasdaq
- INTS Nasdaq
- Market Cap
- BNZI 11.5M
- INTS 12.2M
- IPO Year
- BNZI N/A
- INTS 2023
- Fundamental
- Price
- BNZI $1.31
- INTS $0.41
- Analyst Decision
- BNZI Strong Buy
- INTS Strong Buy
- Analyst Count
- BNZI 1
- INTS 4
- Target Price
- BNZI $30.00
- INTS $4.50
- AVG Volume (30 Days)
- BNZI 492.4K
- INTS 87.7M
- Earning Date
- BNZI 11-14-2025
- INTS 11-06-2025
- Dividend Yield
- BNZI N/A
- INTS N/A
- EPS Growth
- BNZI N/A
- INTS N/A
- EPS
- BNZI N/A
- INTS N/A
- Revenue
- BNZI $10,650,176.00
- INTS N/A
- Revenue This Year
- BNZI $230.60
- INTS N/A
- Revenue Next Year
- BNZI $38.19
- INTS N/A
- P/E Ratio
- BNZI N/A
- INTS N/A
- Revenue Growth
- BNZI 147.06
- INTS N/A
- 52 Week Low
- BNZI $1.28
- INTS $0.19
- 52 Week High
- BNZI $27.00
- INTS $3.18
- Technical
- Relative Strength Index (RSI)
- BNZI 27.56
- INTS 49.37
- Support Level
- BNZI $1.61
- INTS $0.38
- Resistance Level
- BNZI $1.54
- INTS $0.57
- Average True Range (ATR)
- BNZI 0.22
- INTS 0.18
- MACD
- BNZI -0.04
- INTS -0.02
- Stochastic Oscillator
- BNZI 2.84
- INTS 11.18
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About INTS Intensity Therapeutics Inc.
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.